The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

A. Mari; W.M. Sallas; Y.L. He; C. Watson; M. Ligueros-Saylan; B.E. Dunning; Carolyn F. Deacon; Jens Juul Holst; J.E. Foley

The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

A. Mari, W.M. Sallas, Y.L. He, C. Watson, M. Ligueros-Saylan, B.E. Dunning, Carolyn F. Deacon, Jens Juul Holst, J.E. Foley

Endocrinology and Metabolism

334 Citations (Scopus)

Original language	English
Journal	Journal of Clinical Endocrinology and Metabolism
Issue number	90
Pages (from-to)	4888-4894
ISSN	0021-972X
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{336de88074c211dbbee902004c4f4f50,

title = "The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes",

author = "A. Mari and W.M. Sallas and Y.L. He and C. Watson and M. Ligueros-Saylan and B.E. Dunning and Deacon, {Carolyn F.} and Holst, {Jens Juul} and J.E. Foley",

year = "2005",

language = "English",

pages = "4888--4894",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "Oxford University Press",

number = "90",

}

TY - JOUR

T1 - The incretin enhancer vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed -cell function in patients with type 2 diabetes

AU - Mari, A.

AU - Sallas, W.M.

AU - He, Y.L.

AU - Watson, C.

AU - Ligueros-Saylan, M.

AU - Dunning, B.E.

AU - Deacon, Carolyn F.

AU - Holst, Jens Juul

AU - Foley, J.E.

PY - 2005

Y1 - 2005

M3 - Journal article

SN - 0021-972X

SP - 4888

EP - 4894

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 90

ER -